A New Frontier Of Genomics And Aging

Accessible solutions for proactive aging prevention and performance enhancement from the genetic roots with agentic AI

Precision Genome Editing

Novel breakthrough in genome editing technology, designed to achieve highest precision and efficiency

Agentic AI Platform

An LLM-powered, multi-agent platform specialized in genetic interventions automates end-to-end scientific discovery, enabling low-cost, rapid iterations with high confidence and delivering advantageous genetic variants to the general population.

World's First Genome Editing Platform That Can Be Fine Tuned

Proprietary genome editing technology that enables fine tuning of genome editing to optimize precision, efficacy and safety

Safeguard Technology

A revolutionary technology that enhances the safety and precision of genome editing, enabling the development of transformative therapies

7x Editing Efficiency

Continuous fine-tuning is important for determining the optimal editing activity and efficiency

100x Safety

Prioritizes safety by significantly reducing adverse effects such as p53 activation, cytotoxicity and DNA damage, ensuring that gene editing is performed accurately and securely.

3000x Precision

Unparalleled precision, lowering off-targets, enabling genome editing with increased accuracy and control

Meet Our Founders

George Church, PhD

Co-Founder

Professor of Genetics at Harvard Medical School

George Church, PhD, is a world-renowned geneticist who is recognized as a driving force in programmable biology, regenerative medicine, and aging reversal. His breakthroughs include the first direct genome sequencing method, major CRISPR advances, and the Personal Genome Project.